Chronopharmacological studies of ketamine in normal and NMDA Ε1 receptor knockout mice

The effectiveness and toxicity of many drugs depends on the dosing‐time schedule, relative to the circadian rhythms of biochemical, physiological, and behavioural processes. Previous studies have found chronopharmacology of ketamine, which is a N‐methyl‐d‐aspartate (NMDA) receptor antagonist. The in...

Full description

Saved in:
Bibliographic Details
Published in:British journal of anaesthesia : BJA Vol. 92; no. 6; pp. 859 - 864
Main Authors: Sato, Y., Kobayashi, E., Hakamata, Y., Kobahashi, M., Wainai, T., Murayama, T., Mishina, M., Seo, N.
Format: Journal Article
Language:English
Published: Oxford Elsevier Ltd 01-06-2004
Oxford University Press
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The effectiveness and toxicity of many drugs depends on the dosing‐time schedule, relative to the circadian rhythms of biochemical, physiological, and behavioural processes. Previous studies have found chronopharmacology of ketamine, which is a N‐methyl‐d‐aspartate (NMDA) receptor antagonist. The in vivo contribution of the NMDA receptor Ε1 subunit (NR2A) in this effect is unclear. In the present study, daily variations in the hypnotic effect of ketamine were determined in wild‐type mice and NMDA Ε1 knockout (KO) mice. The effect of ketamine had a definite daily variation in wild‐type mice. No significant difference in blood concentration was observed at different dosing times (10:00 and 22:00). In NMDA receptor Ε1 KO mice, the hypnotic effect of ketamine was weaker than in wild‐type mice and there was no dependence on the time of administration. Significant pharmacokinetic differences were not observed between wild‐type and KO mice. The enhanced hypnotic effect in the active phase of the circadian cycle is likely a result of changes with the time of day in the susceptibility of the central nervous system to ketamine. Knockout of the NMDA receptor Ε1 subunit gene markedly reduced the effect of ketamine, and eliminated the time‐dependent sensitivity to ketamine.
Bibliography:local:aeh144
Corresponding author. E‐mail: eijikoba@jichi.ac.jp
istex:B28972F909AB2778631B78F94DAC2DFCCBEB0A9E
ark:/67375/HXZ-ZNWNBMHT-9
Accepted for publication: December 27, 2003
ISSN:0007-0912
1471-6771
DOI:10.1093/bja/aeh144